COVID - 19 Vaccination Update - Day 519 - Prevention is better than cure

Spread the Message

Read Time:1 Minute, 40 Second

Posted On: 18 JUN 2022 8:45PM by PIB Delhi

India’s COVID-19 vaccination coverage has achieved 196 Crore landmark milestone (196,13,24,182) today. More than 11 lakh (11,61,176Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs	1^st Dose	10408261
	2^nd Dose	10055634
	Precaution Dose	5520276
FLWs	1^st Dose	18421883
	2^nd Dose	17610992
	Precaution Dose	9591277
Age Group 12-14 years	1^st Dose	35714238
	2^nd Dose	20996941
Age Group 15-18 years	1^st Dose	60079947
	2^nd Dose	47693230
Age Group 18-44 years	1^st Dose	557879826
	2^nd Dose	497616935
	Precaution Dose	1985880
Age Group 45-59 years	1^st Dose	203383100
	2^nd Dose	192601427
	Precaution Dose	2072105
Over 60 years	1^st Dose	127202650
	2^nd Dose	120248073
	Precaution Dose	22241507
Cumulative 1^st dose administered		1013089905
Cumulative 2^nd dose administered		906823232
Precaution Dose		41411045
Total		1961324182

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 18^th June, 2022 (519^th Day)
HCWs	1^st Dose	85
	2^nd Dose	570
	Precaution Dose	15508
FLWs	1^st Dose	195
	2^nd Dose	1269
	Precaution Dose	63070
Age Group 12-14 years	1^st Dose	67214
	2^nd Dose	196983
Age Group 15-18 years	1^st Dose	23543
	2^nd Dose	78170
Age Group 18-44 years	1^st Dose	26906
	2^nd Dose	262780
	Precaution Dose	99881
Age Group 45-59 years	1^st Dose	4235
	2^nd Dose	61671
	Precaution Dose	45171
Over 60 years	1^st Dose	3670
	2^nd Dose	45207
	Precaution Dose	165048
Cumulative 1^st dose administered		125848
Cumulative 2^nd dose administered		646650
Precaution Dose		388678
Total		1161176

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.